Ken Griffin Surmodics Inc Call Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$25.39 - $42.1 $7,617 - $12,630	300 Added 150.0%	500 $21,000
Q1 2024 May 15, 2024	BUY	$27.44 - $35.56 $2,744 - $3,556	100 Added 100.0%	200 $5,000
Q4 2023 Feb 14, 2024	SELL	$28.47 - $38.49 $8,541 - $11,547	-300 Reduced 75.0%	100 $3,000
Q3 2023 Nov 14, 2023	SELL	$28.28 - $38.36 $65,044 - $88,228	-2,300 Reduced 85.19%	400 $12,000
Q2 2023 Aug 14, 2023	SELL	$17.67 - $31.31 $102,486 - $181,598	-5,800 Reduced 68.24%	2,700 $84,000
Q1 2023 May 15, 2023	BUY	$17.13 - $38.52 $56,529 - $127,116	3,300 Added 63.46%	8,500 $193,000
Q4 2022 Feb 14, 2023	BUY	$29.44 - $37.31 $153,088 - $194,012	5,200 New	5,200 $177,000

124

13.2M

25.5K

3.4K

Ticker SRDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,005,000
Market Cap $551M
Description
Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.